Innovator IBD 50 Fund
ALTAR
Score™
3.7% info Recommen-
dation
UNDERWEIGHT
2020E    2021E
P/E
ratio
24.6x P/Sales
ratio
2.8x
P/BV
ratio
4.3x Div.
yield
0.5%


  • Description
  • Performance
  • Comps
  • premium Fundamentals
  • premium Valuation
  • premium Rating
The Innovator IBD 50 Fund is an active fund that takes the constituents of the IBD 50 Index and reweights them from price-weighted to a proprietary method based on specific fundamental and technical indicators. It holds US-listed stocks and ADRs.

FUND BASICS
Category US Equities
Fund Sponsor Academy Funds
Website www.innovatorfunds.com
Inception date Apr 09, 2015
Assets (mns) $293
Currency USD
Expense ratio 80 bp
Distributions Annually

FUND STRUCTURE
Regulation Open-End Investment Company
Custodian
Weighting Proprietary
Index replication
Uses derivatives No
Options available Yes

SECTOR BREAKDOWN

 


CONSTITUENT BREAKDOWN
No. of constituents 51
Wgt avg mkt cap (mns) $73,195
Large cap (>$10bn) 55.5%
Mid cap ($2-10bn) 26.9%
Small cap (<$2bn) 17.6%
Developed mkts 92.7%
Emerging mkts 7.3%

TOP TEN HOLDINGS
PAYLOCITY HOLDING CORP 3.7 %
NEW ORIENTAL EDUCATIO-SP ADR 3.7 %
PALOMAR HOLDINGS, INC. 3.7 %
SERVICENOW INC 3.6 %
ADOBE SYSTEMS INC 3.6 %
COPART INC 3.5 %
LUMENTUM HOLDINGS, INC. 3.5 %
FORTINET INC 3.4 %
PAYCOM SOFTWARE INC 3.4 %
LULULEMON ATHLETICA INC 3.1 %
Total 35.3 %

TOP COUNTRY EXPOSURE
UNITED STATES 82.8 %
CHINA 7.2 %
CANADA 2.0 %
BRAZIL 1.0 %
NETHERLANDS 0.5 %






HISTORICAL PERFORMANCE info

  Custom date range Compare to  
  thru


Standardized Annual Returns (thru January 31)
Year-to-date 1 year 5 years 10 years Since Incep.
2.0% 14.5% -- -- 8.8%

Market Correlations
versus... Beta R-squared
S&P500 1.25 61%
MSCI EAFE 1.14 41%
MSCI Emg. Mkts. 0.70 28%

Technical Indicators
Recent close $36.64
30d moving avg. $36.06
Annualized volatility 19.5%
Short interest (ETF) 0.2%
Short interest (Underlying) 6.8%
Relative strength (RSI) 63

Liquidity measures
Avg. volume (thou.) 100
Turnover 1.3%
Bid/Ask (% of price) 0.07%
ADV underlying (mns) $15,554

Distributions


FINDING ALTERNATIVE FUNDS

Below is a list of 19 potential alternatives to the Innovator IBD 50 Fund ETF based on the alternatives' overlap in portfolio holdings with FFTY. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.

Benchmark ticker: FFTY Expense: 80 bp ALTAR Score™: 3.7%


ALTERNATIVE ETFs BASED ON OVERLAP WITH FFTY
Ticker Fund
Name
Overlap1
vs FFTY
(%)
Expense
ratio
(bp)
Savings
vs FFTY
(bp)
ALTAR
Score™
(%)
ALTAR
vs FFTY
(%)
RPG Invesco S&P 500 Pure Growth ETF 20.5 35 45 5.0 +1.2
PTF Invesco DWA Technology Momentum 20.5 60 20 2.1 -1.6
AIQ Global X Future Analytics Tech 15.7 68 12 4.0 +0.3
FXL First Trust Technology Alphadex 15.0 63 17 4.2 +0.5
XNTK SPDR NYSE Technology 14.7 35 45 4.4 +0.7
TECB iShares U.S. Tech Breakthrough Multisector ETF 14.2 40 40 4.3 +0.5
ENTR ERShares Entrepreneur 30 13.8 49 31 2.7 -1.1
RYT Invesco S&P Equal Weight Technology 13.7 40 40 6.1 +2.4
FTC First Trust Large Cap Growth 13.6 61 19 3.1 -0.6
CLOU Global X Cloud Computing 13.4 68 12 1.0 -2.7
IGV iShares N. American Tech-Software 13.2 46 34 2.7 -1.1
GENY Principal Millennials Index 13.1 45 35 4.6 +0.9
GVIP Goldman Sachs Hedge Industry VIP 12.8 45 35 5.3 +1.5
QGRO American Century STOXX U.S. Quality Growth 12.7 29 51 5.5 +1.8
OGIG O'Shares Global Internet Giants 12.7 48 32 1.0 -2.7
SKYY First Trust Cloud Computing 12.6 60 20 2.4 -1.4
NUMG NuShares ESG Mid-Cap Growth 12.4 40 40 3.6 -0.1
PLAT WisdomTree Modern Tech Platforms 12.4 45 35 2.2 -1.6
PDP Invesco DWA Technical Leaders 11.8 62 18 3.1 -0.7

1Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.

Content on this tab for subscribers only**

RESULTS & ESTIMATES

  2015 2016 2017 2018 2019 2020E 2021E
Sales per share ** ** ** ** ** ** **
Earnings per share ** ** ** ** ** ** **
Dividends per share info ** ** ** ** ** ** **
Book value per share ** ** ** ** ** ** **

 

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

OTHER FUNDAMENTAL METRICS

Long term EPS growth est. **%   Debt-to-equity **x
Asset turnover **%   Assets-to-equity **x

Return on equity

Revision activity*
*Six months ago = 100

Net margins

Compound annual growth rates

Content on this tab for subscribers only

VALUATION METRICS
  2019 2020E 2021E
Price-to-sales ** ** **
Price-to-earnings ** ** **
Price-to-cash flow ** ** **
Price-to-growth ** ** **
Price-to-book value ** ** **
Yield ** ** **

Historical valuation trends

Forward
multiple:
Innovator IBD 50 Fund
Relative
to:
S&P500 MSCI EAFE MSCI Emg. Mkts. Other ETF:

UNDERWEIGHT

Below average appreciation potential. A rating of UNDERWEIGHT is assigned to ETFs with ALTAR Scores in the 2nd quintile (ranking higher than only 20%-40%) of their category. Typically, funds in this category consist of stocks trading at relatively expensive valuations and/or having below-average fundamentals.

ALTAR Score™


Calculation of ALTAR Score™
Avg. Return on Equity 18.9 %
Divided by: Fwd. P/BV 4.2 x
Less: Expense ratio 80 bp
Equals: ALTAR Score 3.7 %
info More information on ALTAR Score™

MODERN PORTFOLIO THEORY info

CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS
COMPOSITE
RATING
1.38 CATEGORY
AVERAGE
1.56
 
The composite rating is a weighted average of analysts' consensus recommendations for individual ETF constituents, based on the following scale:

BUY = 1; OVERWEIGHT = 1.5, HOLD = 2; UNDERWEIGHT = 2.5; and SELL = 3.

Readers are cautioned that because analyst ratings tend to be inflated, the composite score may be more useful as a relative measure of sentiment between funds rather than as a stand-alone recommendation.
 

 

See RATING tab for calculation of ALTAR Score™
Risk & reward. Uses std. dev. as proxy for risk, ALTAR Score™ for return forecast.
Dividends paid by constituents to the fund. May differ from actual distributions to shareholders due to constituent changes, timing issues or other factors.
Monthly returns based on changes in price plus dividends. May differ from daily returns reported by funds. See below for standardized returns.